Sutinat 50 Sutinat 50 contains Sunitinib Malate 50 mg, an oral targeted therapy used to treat certain types of cancer by blocking proteins that help cancer cells grow and develop new blood vessels. By interrupting these signals, it slows the growth and spread of tumors. Sutinat 50 is commonly prescribed for advanced kidney cancer, gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors. It should be taken only under the guidance of a qualified oncologist.